Abbott RealTime CMV

CE Marked

For In Vitro Diagnostic Use

The Abbott RealTime CMV assay is an in vitro polymerase chain reaction (PCR) assay for the quantitation of cytomegalovirus (CMV) DNA in human plasma or whole blood. 

icon-link.pngInstructions for UseView Ordering Information 
Description
 

The assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of initiation of therapy and for use as an aid in monitoring viral response to antiviral treatment as measured by changes in plasma or whole blood DNA levels.

This assay is not intended to be used as a screening test for CMV or as a diagnostic test to confirm the presence of CMV infection.

Design
 

Development Philosophy

The Abbott RealTime CMV assay uses PCR technology combined with homogeneous real time fluorescent detection for the quantitation of CMV DNA. The selection of two conserved regions of CMV genome provides for the robust and accurate detection of CMV.

Single Stranded Probe Design

  • In the absence of target sequences, the probes adopt a conformation that brings the quencher close enough to the excited fluorophore to absorb its energy before it can be fluorescently emitted.
  • These are linear probes that fold naturally into a random coil to be in the “off” configuration.

Abbott RealTime CMV probe design

  • When the probe binds to its complementary sequence in the target, the fluorophore and the quencher are held apart, allowing fluorescent emission and detection.
  • Since this is fluorescence occurs during every cycle, the PCR reaction can be read and monitored in real-time.

Abbott RealTime CMV probe design

Specifications
 
 
 
Abbott RealTime Cmv
Sensitivity 31.2 IU/mL (20 copies/mL) plasma sample
62.4 IU/mL (40 copies/mL) whole blood sample
Linear range Plasma samples: 31.2 IU/mL to 156 million IU/mL
Whole blood samples: 62.4 IU/mL to 156 million IU/mL
Internal Control Non-competitive pumpkin DNA, added to lysis buffer during extraction
Calibration External two point calibration
Standardization 1st WHO International Standard for Human Cytomegalovirus for Nucleic Acid Amplification Techniques (NIBSC 09/162)
Specimen type Plasma (EDTA) and whole blood (EDTA)
Input volume 0.5 mL plasma, 0.3 mL whole blood
Sample preparation m2000sp - plasma & whole blood
m24 sp and manual - plasma

Ordering Info

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No